- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04552782
PTSD, AUD, and Interpersonal Conflict: Within-person Associations
May 8, 2023 updated by: University of South Dakota
The present study seeks to increase understanding of Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD) among veterans, an important public health concern.
We will study the effects of regulatory deficits and sleep disturbance on the dynamic course of PTSD and AUD.
The study will investigate whether a short, computerized training in the laboratory will alter maladaptive response biases and reduce associations between sleep disturbance, affect and behavioral dysregulation, AUD symptoms, and PTSD symptoms in the real world.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
250
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jeffrey S Simons, PhD
- Phone Number: 605-658-3710
- Email: jeffrey.simons@usd.edu
Study Contact Backup
- Name: Raluca M Simons, PhD
- Phone Number: 605-658-3710
- Email: raluca.simons@usd.edu
Study Locations
-
-
Florida
-
Bay Pines, Florida, United States, 33744
- Not yet recruiting
- Bay Pines VA Health care System
-
Contact:
- Jessica Keith, PhD
- Email: jessica.keith@va.gov
-
Sub-Investigator:
- Jessica Keith, PhD
-
-
South Dakota
-
Sioux Falls, South Dakota, United States, 57105
- Recruiting
- Sioux Falls VA Health Care System
-
Contact:
- Patrick J Ronan, PhD
- Phone Number: 6508 605-336-3230
- Email: patrick.ronan@usd.edu
-
Sub-Investigator:
- Patrick J Ronan, PhD
-
Vermillion, South Dakota, United States, 57069
- Recruiting
- The University of South Dakota
-
Contact:
- Jeffrey S Simons, PhD
- Phone Number: 605-658-3710
- Email: jeffrey.simons@usd.edu
-
Contact:
- Raluca M Simons, PhD
- Phone Number: 605-658-3710
- Email: raluca.simons@usd.edu
-
Principal Investigator:
- Jeffrey S Simons, PhD
-
Principal Investigator:
- Raluca M Simons, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- OIF/OEF/OND veterans
- At risk for PTSD (i.e., PCL-5 ≥33) and/or AUD (i.e., AUDIT ≥ 7 (women) ≥ 8 (men))
Exclusion Criteria:
- Psychosis or severe Alcohol Use Disorder that contraindicates participation (based on interview)
- Active suicidal or homicidal ideation that contraindicates participation (based on interview)
- [exclusion criteria removed 6/2022] - Severe risk for sleep apnea (a positive score in three categories of the Berlin Questionnaire), or reported treatment for sleep apnea
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Alcohol Cognitive Bias Modification (CBM) + PTSD CBM
|
Trains approach or avoidance responses to alcohol cues.
Trains approach or avoidance responses to trauma cues.
|
|
Experimental: Alcohol CBM + PTSD Sham
|
Trains approach or avoidance responses to alcohol cues.
Will not train approach or avoidance responses.
|
|
Experimental: Alcohol Sham + PTSD CBM
|
Trains approach or avoidance responses to trauma cues.
Will not train approach or avoidance responses.
|
|
Sham Comparator: Alcohol Sham + PTSD Sham
|
Will not train approach or avoidance responses.
Will not train approach or avoidance responses.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Alcohol Use Disorder Symptoms
Time Frame: 2 years
|
These are experience sampling items derived from Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
|
2 years
|
|
Rate of PTSD Symptoms
Time Frame: 2 years
|
These are experience sampling items derived from the PTSD Checklist from DSM-5 (PCL-5).
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 4, 2020
Primary Completion (Anticipated)
April 30, 2025
Study Completion (Anticipated)
April 30, 2025
Study Registration Dates
First Submitted
September 10, 2020
First Submitted That Met QC Criteria
September 10, 2020
First Posted (Actual)
September 17, 2020
Study Record Updates
Last Update Posted (Actual)
May 9, 2023
Last Update Submitted That Met QC Criteria
May 8, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Chemically-Induced Disorders
- Alcohol-Related Disorders
- Substance-Related Disorders
- Trauma and Stressor Related Disorders
- Stress Disorders, Traumatic
- Alcoholism
- Stress Disorders, Post-Traumatic
- Physiological Effects of Drugs
- Anti-Infective Agents, Local
- Anti-Infective Agents
- Central Nervous System Depressants
- Ethanol
Other Study ID Numbers
- 1R01MH122954 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcoholism
-
Yale UniversityCompletedFamilial Alcoholism VulnerabilityUnited States
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingFamilial Alcoholism VulnerabilityUnited States
-
Yonsei UniversityTerminated
-
University of Southern DenmarkActive, not recruitingGeneral Practice | Alcohol Abuse Alcoholism | Screening and Brief InterventionDenmark
-
University of FloridaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedEffects of Family History of Alcoholism and Sex on Alcohol AnalgesiaUnited States
-
Versailles HospitalNot yet recruiting
-
Khoo Teck Puat HospitalNot yet recruitingEmergencies | Alcohol Use Disorder | Alcoholism and Alcohol Abuse
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcoholic Liver Disease | Alcoholism,United States
-
Johns Hopkins UniversityNational Institutes of Health (NIH); Idorsia Pharmaceuticals Ltd.Not yet recruitingAlcohol Use Disorder
-
Zealand University HospitalNot yet recruiting
Clinical Trials on Alcohol CBM
-
Han Joo LeePsi ChiRecruiting
-
Florida State UniversityCompletedIntolerance of Uncertainty; AnxietyUnited States
-
University of Texas at AustinCompletedSocial Anxiety DisorderUnited States
-
Beijing Normal UniversityUnknownInternet Gaming DisorderChina
-
St Vincent's Hospital, SydneyCompleted
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenCompleted
-
Kaiser PermanenteNational Institute of Mental Health (NIMH)Unknown
-
Florida State UniversityMilitary Suicide Research ConsortiumCompletedMilitary Service Members at Elevated Suicide RiskUnited States
-
The University of Hong KongRecruitingSuicidal Ideation | Self-Harm, Deliberate | MasculinityHong Kong